GlassScriptPhysician profile
Angela O Withee
NPI 1013410976
$974.52
in general payments reported to CMS, 2019-2025
18 companies · $193 in 2025
The $193 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $137 · 2022: $178 · 2023: $219 · 2024: $246 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $658.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $330.38 | 2021-2025 | |
| Exact Sciences Corporation | $98.64 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $52.21 | 2024-2025 | Mounjaro |
| Organon LLC | $48.15 | 2022-2023 | Nexplanon |
| Glaxosmithkline, LLC. | $47.99 | 2024-2025 | Arexvy |
| Dexcom, INC. | $47.87 | 2021-2024 | Dexcom G6 Transmitter |
| Cequr Corporation | $45.79 | 2024-2025 | Cequr Simplicity |
| Galderma Laboratories, L.P. | $44.56 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.97 | 2021-2022 | |
| Novo Nordisk INC | $43.17 | 2021-2025 | Wegovy |
| Pfizer INC. | $34.76 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $32.38 | 2023-2024 | Breztri, Farxiga |
| Merck Sharp & Dohme LLC | $25.79 | 2021 | |
| Phathom Pharmaceuticals, INC. | $19.93 | 2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $16.95 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.67 | 2025 | Caplyta |
| Biogen, INC. | $12.95 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Withee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.